SAN DIEGO (AP) — SAN DIEGO (AP) — ImmunityBio, Inc. (IBRX) on Thursday reported a loss of $632.8 million in its first quarter.
The San Diego-based company said it had a loss of 62 cents per share. Losses, adjusted for non-recurring costs, were 9 cents per share.
The immunotherapy company posted revenue of $44.2 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IBRX at https://www.zacks.com/ap/IBRX
/Advanced%20Micro%20Devices%20Inc_%20logo%20on%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
/Intel%20Corp_%20badge%20holder-by%20hasrul_rais%20via%20Shutterstock.jpg)
/Palantir%20by%20Hiroshi-Mori-Stock%20via%20Shutterstock.jpg)
/Robinhood%20app%20on%20phone%20by%20Andrew%20Neel%20via%20Unsplash.jpg)